Esperancepharma’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Esperance is a clinical stage company, that develops targeted anticancer drugs. Read more

Esperance is a clinical stage company, that develops targeted anticancer drugs. Read more

Hector Alila's photo - President & CEO of Esperancepharma

President & CEO

Hector Alila

CEO Approval Rating

68/100

Founded:

01/2005

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 49 a good estimate for Esperancepharma's Employee count?

Acquisitions

No recent acquisitions found related to Esperancepharma

Esperancepharma Funding History

$7.5M$8.5M

Since Esperancepharma was founded in 01/2005, it has participated in 2 rounds of funding. In total Esperancepharma has raised $8.5M. Esperancepharma's last funding round was on Jun 2019 for a total of $1.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Jun 2019
$1M
-
Series B
May 2011
$7.5M

Since Esperancepharma was founded in 01/2005, it has participated in 2 rounds of funding. In total Esperancepharma has raised $8.5M. Esperancepharma's last funding round was on Jun 2019 for a total of $1.0M

Investments

No recent investments found related to Esperancepharma

Esperancepharma News

April 3, 2016The Business Journals: Houston

New-to-Houston biotech company on lookout for headquarters

Esperance Pharmaceuticals, a Baton Rouge, Louisiana-based cancer therapeutics company, has relocated ... See more »
March 17, 2016BioSpace

Esperance Pharmaceuticals, Inc. Names To Board Of Directors

Life Sciences Jobs ...... See more »
August 24, 2015THE PHARMA LETTER

Esperance links with MD Anderson Cancer Center to test EP-100

Esperance Pharmaceuticals has entered into a strategic alliance agreement with MD Anderson Cancer Cen... See more »
May 31, 2015BIOSPACE

Esperance Pharmaceuticals, Inc. Reports Positive EP-100 Phase Ll Results In Ovarian Cancer At 2015 <B>ASCO</B> Annual Meeting

BATON ROUGE, La., June 1, 2015 /PRNewswire/ -- Esperance Pharmaceuticals Inc. today reported positive... See more »

Esperancepharma Press Releases

June 1, 2015PR NEWSWIRE

Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting

BATON ROUGE, La., June 1, 2015 /PRNewswire/ -- Esperance Pharmaceuticals Inc. today reported positive... See more »
May 26, 2015PR-INSIDE.COM

Esperance Pharmaceuticals, Inc. - Product Pipeline Review - 2014 By Radiant Insights

(PR-inside.com) Esperance Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Marke... See more »

Social Media

Headquarters

909 Fannin Street Suite 2000

Houston, Texas77010

225-615-8944

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Esperance is a clinical stage company, that develops targeted anticancer drugs. Esperancepharma was founded in 01/2005. Esperancepharma's headquarters is located in Houston, Texas, USA 77010. It has raised 8.5M in 2 rounds. The latest round was in Jun...

CEO

Esperancepharma's President & CEO, Hector Alila, currently has an approval rating of 68%. Esperancepharma's primary competitors are

Website

esperancepharma.com

Frequently Asked Questions about Esperancepharma

  1. When was Esperancepharma founded?

    Esperancepharma was founded in 01/2005
  2. Who is Esperancepharma's CEO?

    Esperancepharma's CEO is Hector Alila
  3. How much revenue does Esperancepharma generate?

    Esperancepharma generates $8.8M in revenue
  1. How much funding does Esperancepharma have?

    Esperancepharma has historically raised $8.5M in funding
  2. Where is Esperancepharma's headquarters?

    Esperancepharma's headquarters is in Houston Texas, USA
  3. How many employees does Esperancepharma have?

    Esperancepharma has 49 employees